HOME >> MEDICINE >> NEWS
Alzheimers disease - recent discoveries pave the way toward new treatments

Promising research into the causes of Alzheimer's disease, with an emphasis on the roles of such proteins as amyloid-beta and apolipoprotein E, will be the subject of a plenary session presentation on April 29 at the American Academy of Neurology (AAN) 56th Annual Meeting in San Francisco.

Lennart Mucke, MD, director of the Gladstone Institute of Neurological Disease and Joseph B. Martin Distinguished Professor of Neuroscience at the University of California, San Francisco (UCSF), will discuss the latest therapeutic targets and describe molecular markers of cognitive decline that may facilitate the assessment of new treatments for Alzheimer's disease.

"Ongoing studies are beginning to unravel the pathways that lead from the accumulation of toxic proteins in the brain to the biochemical alterations and cognitive decline in patients with Alzheimer's disease," says Mucke.

His talk, "Markers and Mediators of Neuronal Deficits in Dementia," will highlight recent discoveries that shed light on the processes underlying the memory loss and other cognitive deficits associated with Alzheimer's disease. The presentation is part of "Frontiers in Clinical Neurosciences Plenary Session: Beyond the Decade of the Brain," during which several scientists will present recent research findings and discuss their clinical implications.

"Recently, we identified a number of mechanistically informative changes in the brains of transgenic mouse models of Alzheimer's disease, and we have begun to validate the clinical relevance of these findings in human cases," explains Mucke. "For instance, deficits in spatial learning and memory in our mice correlated tightly with the depletion of calcium-dependent proteins in specific brain regions. Similar abnormalities were then found in brains from patients with Alzheimer's disease, and the greatest depletions were seen in the most severely demented people."

Mucke's talk will focus on these and other key findin
'"/>

Contact: John Watson
jwatson@gladstone.ucsf.edu
415-695-3833
University of California - San Francisco
26-Apr-2004


Page: 1 2 3

Related medicine news :

1. Researchers identify novel method of distinguishing Alzheimers disease from other types of dementia
2. Down syndrome study reveals possible method for detecting initial stages of Alzheimers
3. Synthetic marijuana reduces agitation in patients with Alzheimers
4. Caregivers refuse Alzheimers medications when patients quality of life threatened
5. New prevalence study suggests dramatically rising numbers of people with Alzheimers disease
6. Benefits of treating behavioral, functional problems caused by Alzheimers disease
7. Seeing into the Alzheimers brain
8. OHSU takes part in unique Alzheimers treatment trial
9. UCLA Study shows how early diagnosis of Alzheimers helps patients
10. Moderately high homocysteine tied to stroke, Alzheimers risk
11. Growing evidence that commonly used medicines may delay or prevent Alzheimers disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... Want to get moving, break up your routine, ... (CPARF) is thrilled to launch its fourth annual STEPtember campaign in the United States ... meets everyone wherever they are at this moment — encouraging people to move in ...
(Date:8/31/2020)... ... 31, 2020 , ... Colorado State University Global (CSU Global) ... online education – is proud to announce its new master’s degree in ... kind in the nation, the 60-credit hour program is designed to provide students ...
(Date:8/31/2020)... ... ... economic outlook continues to put financial strain on many of us, so it just makes ... monthly expenses and put more into savings, if possible. , “That’s a great way to ... in place in case something were to happen to you,” says Lee Duncan, CMO & ...
(Date:8/31/2020)... ... 2020 , ... In an effort to give back to the community in ... each hotel room booked with a special new rate code to benefit children and ... effective immediately. Donations will be applied to any room type, any time, now ...
(Date:8/31/2020)... ... August 31, 2020 , ... Bonde Innovations, LLC, a venture-backed ... heart failure, today announced that the company has been awarded a Phase 1 ... National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH). ...
Breaking Medicine News(10 mins):
(Date:8/31/2020)... Israel (PRWEB) , ... August 31, 2020 , ... ... specialize in wellness-related technologies, today announced that they have invested $400,000 in PopBase, ... that ran in collaboration with the Global Wellness Institute (GWI). , The ...
(Date:8/28/2020)... ... 2020 , ... Dr. Mark Surrey has been in practice for over ... clinical professor in the Department of OBGYN at UCLA’s David Geffen School of Medicine. ... Reproductive Society and is a Clinical Director of Fellowship Training for UCLA & Cedars ...
(Date:8/27/2020)... ... , ... Bleep LLC, maker of the DreamPort mask-less CPAP solution, announced today ... spokesperson. , “In my line of work, a good night of sleep is critical ... was a Bleeping no brainer for me,” said Jensen. “From the moment I started ...
Breaking Medicine Technology:
Cached News: